CETIRIZINE HYDROCHLORIDE TABLETS

País: Canadá

Idioma: inglés

Fuente: Health Canada

Ingredientes activos:

CETIRIZINE HYDROCHLORIDE

Disponible desde:

VITA HEALTH PRODUCTS INC

Código ATC:

R06AE07

Designación común internacional (DCI):

CETIRIZINE

Dosis:

20MG

formulario farmacéutico:

TABLET

Composición:

CETIRIZINE HYDROCHLORIDE 20MG

Vía de administración:

ORAL

Unidades en paquete:

100

tipo de receta:

Prescription

Resumen del producto:

Active ingredient group (AIG) number: 0122686003; AHFS:

Estado de Autorización:

APPROVED

Fecha de autorización:

2022-12-01

Ficha técnica

Pr
Cetitrizine Hydrochloride Tablets
Page 1 of 31
PRODUCT MONOGRAPH
PR
CETIRIZINE HYDROCHLORIDE TABLETS
20MG
MFR. STD.
Histamine H
1
Receptor Antagonist
Vita Health Products Inc.
Date of Preparation:
150 Beghin Avenue
November 29, 2022
Winnipeg,
MB
R2J 3W2
Control Number: 264926
Pr
Cetitrizine Hydrochloride Tablets
Page 2 of 31
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................................. 3
SUMMARY PRODUCT INFORMATION
................................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
........................................................................................................
3
WARNINGS AND PRECAUTIONS
.........................................................................................
3
ADVERSE REACTIONS
........................................................................................................
5
DRUG INTERACTIONS
........................................................................................................
7
DOSAGE AND ADMINISTRATION
.......................................................................................
7
OVERDOSAGE
.....................................................................................................................
8
ACTION AND CLINICAL PHARMACOLOGY
........................................................................
9
STORAGE AND STABILITY
...............................................................................................
10
DOSAGE FORMS, COMPOSITION AND PACKAGING
......................................................... 10
PART II: SCIENTIFIC INFORMATION
....................................................................................
12
PHARMACEUTICAL INFORMATION
.................................................................................
12
CLINICAL TRIALS
..............................................